October 2, 2017 / 10:58 AM / 9 months ago

BRIEF-Lannett receives two FDA approvals for Lansoprazole, one each for full prescription and OTC

Reuters Staff

1 Min Read

Oct 2 (Reuters) - Lannett Company Inc:

* Lannett receives two fda approvals for Lansoprazole delayed-release capsules usp, one each for full prescription and OTC

* Lannett Company Inc - co expect to commence marketing our prescription Lansoprazole delayed-release capsules product in next several months Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below